期刊文献+

心力衰竭患者如何应用醛固酮拮抗剂 被引量:4

下载PDF
导出
摘要 近年的研究显示,在心衰的发生发展过程中,神经内分泌系统长期过度激活是慢性心力衰竭进行性恶化的重要原因,抑制交感神经系统和肾素-血管紧张素-醛固酮系统(RAAS)的过度激活是慢性心力衰竭治疗的关键,醛固酮拮抗剂是继血管紧张素转换酶抑制剂(ACEI)和β受体阻滞剂之后第三个能够降低心力衰竭患者病死率的药物。
作者 赵丽
出处 《中国医刊》 CAS 2012年第6期23-25,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献12

  • 1Rochar F. Williams GH. Rationale for the use Aldosterone antagonists in congestive heart failure [ J ]. Drugs,2002,62 ( 5 ) : 723 - 731.
  • 2Foo RS,Mani K, Kitsis RN. Death begets failure in the heart[J]. J Clin Invest,2005,115 (3) : 365.
  • 3Davila DF, Nunez TJ, Odrenman R et al. Mechanism of neurohormon- al activation in chronic congestive heart failure:pathophysiology and therapeutic implication [ J ]. Int J Cardio1,2005 ; 101 : 343.
  • 4Silvestre JS,Robert V, Heymes C,et al. Myocardial production of al- dostcrone and corticosterone in the rat physiological regulation [ J ]. J Biol Chem, 1998,273 (9) : 4883 - 4891.
  • 5Arrogon D, Burger AJ. Neurohumoral activation and ventricular ar- rhythmia in patents with decompensated congestive heart failure:role of endothelin Pacing[J]. Clin Electrophysiol,2003 ;26: 703.
  • 6Fritsch NM,Schiffrin EL. Aldosterone:a risk factor for vascular dis- ease[ J]. Curt Hypertens Rep,2003.5 ( 1 ) : 59 - 65.
  • 7Staessen J,lijnen P,Fagard R,et al. Rise in plasma concentration of aldosterone during long-term angiotensin suppression [ J ]. Endocri- nology, 1981,91 : 457 - 465.
  • 8Weber KT, Brilla OG, pathological hypertrophy and cardiac interstiti- um fibrosis and rennin-angiotensin-aldosterone system [ J ]. Cicula- tion,1991,83 (6) : 1849.
  • 9Pitt B, Zannad F, Remme WJ et al. The Randomized Aldactone eval- uation study investigators. The effect of Spironolactone on morbility and mortality in patients with severe heart failure [ J ]. N Engl Meal, 1999 ;341 : 709 - 777.
  • 10Pitt B, Remmew J, Zannad F, et al. Epleronone, a selective aldoste- rone blocker in patients with 1 eft ventricular dysfunction after a myo- cardial infarction[ J]. N Engl J Med,2003,348 (14): 1309.

二级参考文献4

  • 1Swedberg K, Komajda M, Bohm M, et al. lvahradine and outcomes in chronic heart failure (SHIFF) : a randomised placebo-controlled study. Lancet,2010, 376(9744) :875-885.
  • 2Zannad F, McMurray J J, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med ,2011,364 (1) :11-21.
  • 3ASCEND-HF study Clinical trial results database:Nesiritide-vasodilatots therapy for heart failure, http://www, trialresuhseenter, org/study7337-ASCENDHF. htm,.
  • 4Tong AS, Wells GA, Talajie M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med,2010,363 ( 25 ) : 2385-2395.

共引文献45

同被引文献36

  • 1曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
  • 2马虹.重组人类脑钠肽在心力衰竭治疗中的作用[J].新医学,2007,38(10):685-687. 被引量:25
  • 3胡大一,严晓伟.β肾上腺素能受体阻滞剂的规范使用.北京:人民卫生出版社,2009:223-254.
  • 4McNamara DM.Pharmacogenomics for neurohormonal intervention in heart failure.Cardiol Clin,2008,26(1):127-135,viii.
  • 5Braunwald E.Expanding indications for beta-blockers in heart failure.N Engl J Med,2001,344(22):1711-1712.
  • 6中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2007,12(35):1076-1095.
  • 7Hunt SA,Baker DW, Chin MH,et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the aduh:a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guide lines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) [J]. Circulation, 2001, 104(24) :2996-3007.
  • 8Hunt SA,Abraham WT,Chin MH,et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 200l Guidelines for the Evaluation and Management of Heart Failure) :Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:Endorsed by the Heart Rhythm Society [J]. Circulation, 2005,112 ( 12 ) : 154-235.
  • 9Hunt SA,Abraham WT,Chin MH,et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in aduhs:a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide lines [J]. J Am Coil Cardio1,2009,53 (15):1-90.
  • 10Yancy CW,Jessup M,Bozkurt B,et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2013,128 (16) : 240-319.

引证文献4

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部